Table 1.
Individual cardiac characteristics of participants with CHF.
| Patient # | Gender | LVEF% | Etiology of CHF |
|---|---|---|---|
| STUDY GROUP-CHF CHILDREN | |||
| 1 | M | 39 | VSD, PHTN |
| 2 | F | 40 | VSD |
| 3 | F | 19 | Dilated cardiomyopathy |
| 4 | M | 42 | VSD + ASD, PS |
| 5 | F | 47 | VSD |
| 6 | M | 50 | VSD |
| 7 | M | 35 | Dilated cardiomyopathy |
| 8 | F | 12 | Dilated cardiomyopathy |
| 9 | M | 50 | VSD, PHTN |
| 10 | F | 34 | VSD |
| CONTROL GROUP-CHF ADULTS | |||
| 21 | M | 35 | Ischemic cardiomyopathy |
| 22 | F | 30 | Ischemic cardiomyopathy |
| 23 | M | 20 | Ischemic cardiomyopathy |
| 24 | M | 45 | Rheumatic heart disease, recurrent endocarditis |
| 25 | F | 15 | Ischemic cardiomyopathy |
| 26 | M | 25 | Ischemic cardiomyopathy |
| 27 | M | 15 | Valvular heart disease |
| 28 | F | 20 | Valvular heart disease |
| 29 | M | 35 | Ischemic cardiomyopathy |
| 30 | M | 25 | Ischemic cardiomyopathy |